Kraig Biocraft Laboratories Inc
kraiglabs.comKraig Biocraft Laboratories (OTC: KBLB) is a biotechnology company that develops recombinant spider silk fibers using genetically engineered silkworms. The company inserts spider silk protein gene sequences into silkworm embryos to produce high-strength, lightweight fibers intended for commercial textile and technical applications. Target end markets include performance apparel, workwear, filtration, luxury fashion, medical textiles, geotextiles, and ballistic-resistant materials. As of the fiscal year ended December 31, 2025, the company reported zero revenue, funding operations through equity sales under a Standby Equity Purchase Agreement (SEPA) and proceeds from the sale of a gold bullion investment ($443,437 in FY2025). The company holds patents issued across Vietnam, South Korea, Australia, Canada, France, and Germany, derived in part from a joint development program with the University of Notre Dame. Kraig Labs operates research and production infrastructure in Vietnam. The company is pre-commercial, carrying an accumulated deficit, and has relied on stock issuances and debt instruments to finance operations through at least December 31, 2025.
Products & Services
Recombinant spider silk fiber produced via transgenic silkworms. Applications include performance apparel, workwear, filtration, luxury fashion, medical textiles, geotextiles, and ballistic-resistant materials. No commercial products were generating revenue as of December 31, 2025.
Revenue Model
No product revenue as of FY2025 (December 31, 2025). The company has financed operations through equity issuances, including $2,602,900 in stock sale proceeds in FY2025, and a SEPA facility with a third-party investor. Additional cash in FY2025 came from the sale of a gold bullion investment ($443,437 net proceeds).
Customers & Markets
No commercial customers as of December 31, 2025. Target end markets include technical textiles, performance apparel, workwear, filtration, luxury fashion, medical textiles, geotextiles, and ballistic protection. The company is in pre-commercial development stage.
Geographic Exposure
Research and development facility opened in 2017 (location unspecified in excerpts). Production and operational presence in Vietnam. Patents issued in Vietnam, South Korea, Australia, Canada, France, and Germany as of the filing date (2026-03-30). Incorporated in Wyoming.
Financial Snapshot
Loading...
